Natriuretic peptides and cardio-renal disease
Author:
Open Access
- 1 October 2014
- journal article
- review article
- Published by Elsevier in International Journal of Cardiology
- Vol. 176 (3) , 630-639
Abstract
No abstract availableKeywords
Funding Information
- Novartis Pharma AG, Basel, Switzerland
This publication has 130 references indexed in Scilit:
- Aortic Stiffness, Blood Pressure Progression, and Incident HypertensionJAMA, 2012
- Endothelial actions of atrial and B‐type natriuretic peptidesBritish Journal of Pharmacology, 2012
- Sustained Blood Pressure–Lowering Actions of Subcutaneous B-Type Natriuretic Peptide (Nesiritide) in a Patient With Uncontrolled HypertensionMayo Clinic Proceedings, 2012
- Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approachesEuropean Heart Journal, 2011
- A Genetic Variant of the Atrial Natriuretic Peptide Gene Is Associated With Cardiometabolic Protection in the General CommunityJACC, 2011
- Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressureNature Genetics, 2009
- Emerging roles of natriuretic peptides and their receptors in pathophysiology of hypertension and cardiovascular regulationJournal of the American Society of Hypertension, 2008
- Design, Synthesis, and Actions of a Novel Chimeric Natriuretic Peptide: CD-NPJACC, 2008
- Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin‐mediated angioedemaBritish Journal of Pharmacology, 2008
- Natriuretic peptide C receptor signalling in the heart and vasculatureThe Journal of Physiology, 2008